Clinical significance of concomitant bacteriuria in patients with Staphylococcus aureus bacteraemia.
Matthaios Papadimitriou-OlivgerisDamien JacotLaurence SennBenoit GueryPublished in: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology (2023)
This retrospective study, conducted at Lausanne University Hospital (2015-2021), compared Staphylococcus aureus bacteraemia (SABA) patients with or without concomitant bacteriuria (SABU). Among 448 included bacteraemic patients, 62 (13.8%) had S. aureus concurrently isolated from urine. In multivariate analysis, there was a significant difference in the odds of community-onset bacteraemia (P 0.030), malignancy (P 0.002), > 1 pair of positive blood cultures (P 0.037), and persistent bacteraemia for at least 48 h (P 0.045) in patients with concurrent SABU. No difference concerning mortality was found. On the other hand, SABU was associated with higher rates of SABA recurrence after antibiotic cessation.
Keyphrases
- staphylococcus aureus
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- healthcare
- mental health
- prognostic factors
- peritoneal dialysis
- biofilm formation
- cardiovascular events
- urinary tract infection
- squamous cell carcinoma
- type diabetes
- locally advanced
- methicillin resistant staphylococcus aureus
- coronary artery disease
- data analysis